Inger van Steenoven

1.3k total citations
21 papers, 745 citations indexed

About

Inger van Steenoven is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Inger van Steenoven has authored 21 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 13 papers in Physiology and 12 papers in Neurology. Recurrent topics in Inger van Steenoven's work include Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (12 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Inger van Steenoven is often cited by papers focused on Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (12 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Inger van Steenoven collaborates with scholars based in Netherlands, United Kingdom and United States. Inger van Steenoven's co-authors include Afina W. Lemstra, Charlotte E. Teunissen, Wiesje M. van der Flier, Philip Scheltens, Jessica J. van der Zande, Marleen van de Beek, Dag Aarsland, Cornelis J. Stam, Wilma D. J. van de Berg and Alida A. Gouw and has published in prestigious journals such as Neurology, International Journal of Molecular Sciences and Movement Disorders.

In The Last Decade

Inger van Steenoven

21 papers receiving 731 citations

Peers

Countries citing papers authored by Inger van Steenoven

Since Specialization

Citations

This map shows the geographic impact of Inger van Steenoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger van Steenoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger van Steenoven more than expected).

Fields of papers citing papers by Inger van Steenoven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger van Steenoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger van Steenoven. The network helps show where Inger van Steenoven may publish in the future.

Co-authorship network of co-authors of Inger van Steenoven

This figure shows the co-authorship network connecting the top 25 collaborators of Inger van Steenoven. A scholar is included among the top collaborators of Inger van Steenoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger van Steenoven. Inger van Steenoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment 2022 ·International Journal of Geriatric Psychiatry ·Marleen van de Beek, (unknown), Inger van Steenoven, (unknown), Frederik Barkhof, Charlotte E. Teunissen, Wiesje M. van der Flier, Afina W. Lemstra	6
2	Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies 2021 ·Journal of Alzheimer s Disease ·Sven J. van der Lee, Inger van Steenoven, Marleen van de Beek, Niccoló Tesi, Iris E. Jansen, Natasja M. van Schoor, Marcel Reinders, Martijn Huisman, Philip Scheltens, Charlotte E. Teunissen, Henne Holstege, Wiesje M. van der Flier, Afina W. Lemstra	20
3	Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results 2021 ·Alzheimer s Research & Therapy ·Marleen van de Beek, Inger van Steenoven, Jessica J. van der Zande, (unknown), Frederik Barkhof, Cornelis J. Stam, Pieter G. Raijmakers, Philip Scheltens, Charlotte E. Teunissen, Wiesje M. van der Flier, Afina W. Lemstra	27
4	Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression 2020 ·Movement Disorders ·Marleen van de Beek, Inger van Steenoven, Jessica J. van der Zande, Frederik Barkhof, Charlotte E. Teunissen, Wiesje M. van der Flier, Afina W. Lemstra	51
5	Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF 2020 ·Cells ·Walter Boiten, Inger van Steenoven, Mei-Fang Xiao, Paul Worley, Barbara Noli, (unknown), Gian‐Luca Ferri, Afina W. Lemstra, Charlotte E. Teunissen	23
6	Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies 2020 ·Alzheimer s Research & Therapy ·Marleen van de Beek, (unknown), Inger van Steenoven, Hugo Vanderstichele, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra, Wiesje M. van der Flier	25
7	Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach 2020 ·Molecular Neurodegeneration ·Inger van Steenoven, Marleen J.A. Koel‐Simmelink, Leonie J.M. Vergouw, Betty M. Tijms, Sander R. Piersma, Thang V. Pham, Claire Bridel, Gian‐Luca Ferri, Cristina Cocco, Barbara Noli, Paul Worley, Mei-Fang Xiao, Desheng Xu, Patrick Oeckl, Markus Otto, Wiesje M. van der Flier, Frank Jan de Jong, Connie R. Jiménez, Afina W. Lemstra, Charlotte E. Teunissen	54
8	Mild cognitive impairment with Lewy bodies: Clinical characteristics and risk factors for progression 2020 ·Alzheimer s & Dementia ·Marleen van de Beek, Inger van Steenoven, Jessica J. van der Zande, Frederik Barkhof, Charlotte E. Teunissen, Wiesje M. van der Flier, (unknown)	1
9	Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies 2020 ·Neurology ·Jessica J. van der Zande, Alida A. Gouw, Inger van Steenoven, Marleen van de Beek, Philip Scheltens, Cornelis J. Stam, Afina W. Lemstra	33
10	VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies 2019 ·International Journal of Molecular Sciences ·Inger van Steenoven, Barbara Noli, Cristina Cocco, Gian‐Luca Ferri, Patrick Oeckl, Markus Otto, Marleen J.A. Koel‐Simmelink, Claire Bridel, Wiesje M. van der Flier, Afina W. Lemstra, Charlotte E. Teunissen	25
11	Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer’s Disease 2019 ·Journal of Alzheimer s Disease ·Marleen van de Beek, Inger van Steenoven, Inez H.G.B. Ramakers, Pauline Aalten, Huiberdina L. Koek, Marcel G. M. Olde Rikkert, Judith Manniën, Janne M. Papma, Frank Jan de Jong, Afina W. Lemstra, Wiesje M. van der Flier	33
12	Family History is Associated with Phenotype in Dementia with Lewy Bodies 2019 ·Journal of Alzheimer s Disease ·Leonie J.M. Vergouw, (unknown), Marleen van de Beek, (unknown), (unknown), Inger van Steenoven, Gerwin Roks, Vincenzo Bonifati, John C. van Swieten, Afina W. Lemstra, Frank Jan de Jong	2
13	Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies 2019 ·Alzheimer s Research & Therapy ·Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra	30
14	α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies 2018 ·Movement Disorders ·Inger van Steenoven, Nour K. Majbour, Nishant N. Vaikath, Henk W. Berendse, Wiesje M. van der Flier, Wilma D. J. van de Berg, Charlotte E. Teunissen, Afina W. Lemstra, Omar M. A. El‐Agnaf	86
15	EEG Characteristics of Dementia With Lewy Bodies, Alzheimer’s Disease and Mixed Pathology 2018 ·Frontiers in Aging Neuroscience ·Jessica J. van der Zande, Alida A. Gouw, Inger van Steenoven, Philip Scheltens, Cornelis J. Stam, Afina W. Lemstra	57
16	An update on the genetics of dementia with Lewy bodies 2017 ·Parkinsonism & Related Disorders ·Leonie J.M. Vergouw, Inger van Steenoven, Wilma D. J. van de Berg, Charlotte E. Teunissen, John C. van Swieten, Vincenzo Bonifati, Afina W. Lemstra, Frank Jan de Jong	31
17	[P1–243]: ALPHA‐SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES 2017 ·Alzheimer s & Dementia ·Inger van Steenoven, Nour K. Majbour, Nishant N. Vaikath, Henk W. Berendse, Wiesje M. van der Flier, Wilma D. J. van de Berg, Charlotte E. Teunissen, Omar M. A. El‐Agnaf, Afina W. Lemstra	2
18	Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia 2016 ·Movement Disorders ·Carla Abdelnour, Inger van Steenoven, Elisabet Londos, ‪Frederic Blanc‬, Bjørn Auestad, Milica G. Kramberger, Henrik Zetterberg, Brit Mollenhauer, Merçé Boada, Dag Aarsland	70
19	Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort 2016 ·Journal of Alzheimer s Disease ·Inger van Steenoven, Dag Aarsland, Daniel Weintraub, Elisabet Londos, ‪Frederic Blanc‬, Wiesje M. van der Flier, Charlotte E. Teunissen, Brit Mollenhauer, Tormod Fladby, Milica G. Kramberger, Laura Bonanni, Afina W. Lemstra	78
20	Conversion between Mini‐Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale‐2 scores in Parkinson's disease 2014 ·Movement Disorders ·Inger van Steenoven, Dag Aarsland, Howard Hurtig, Alice Chen‐Plotkin, John E. Duda, Jacqueline Rick, Lana M. Chahine, Nabila Dahodwala, John Q. Trojanowski, David R. Roalf, Paul J. Moberg, Daniel Weintraub	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact